Nicole M Iovine

Nicole M Iovine, MD, PhD

Clinical Professor, Hospital Epidemiologist and Interim Chief of Hematology/Oncology

Department: MD-INFECTIOUS DISEASES
Business Phone: (352) 273-8606

On This Page

About Nicole M Iovine

Additional Positions:
Section Chief, Epidemiology and Antimicrobial Stewardship
2018 – Current · University of Florida

Accomplishments

  1. Fellow of the Infectious Disease Society of America

    Infectious Disease Society of America

  2. Outstanding Leadership in Quality and Patient Safety

    University of Florida Health

  3. Excellence in Teaching Award

    University of Florida

  4. Special Citation of Excellence for a Poster Presentation

    43rd Annual Meeting of the IDSA

  5. Infectious Disease Fellow of the Year

    New York University

  6. Alpha Omega Alpha Honor Society

    New York University School of Medicine

  7. Golden Key National Honor Society

    City University of New York

  8. Valedictorian

    City University of New York

Teaching Profile

Courses Taught

  1. MDT7200 – Elect Top/Medicine

    College of Medicine

  2. BMS6300 – Fund Micro and Immuno

    College of Medicine

Board Certifications

  • Infectious Disease
    American Board of Internal Medicine
  • Internal Medicine
    American Board of Internal Medicine

Clinical Profile

Specialties

  • Infectious Disease

Areas of Interest

  • Avian Influenza
  • Coronavirus Disease 2019 (COVID-19)
  • Infectious Diseases

Research Profile

I am trained as both an Infectious Disease specialist and as an expert in innate defense against bacterial infection, with a focus on Gram-negative organisms.  As an Infectious Disease specialist, I am particularly interested in treatment approaches to multidrug-resistant Gram-negative infections.  As a researcher, I study the innate defenses against these types of infections.  In one project, I study the Bactericidal/Permeability-Increasing protein (BPI) – an endogenous antibiotic found in neutrophils and available in recombinant form. BPI has potent activity against Gram-negative bacteria, including multidrug-resistant clinical isolates I collect.

I have also studied emerging infections, such as chikungunya, Zika and seasonal influenza. I was engaged in two NIH-sponsored clinical trials for the treatment of seasonal influenza with immune plasma and triple therapy (ribivirin, oseltamivir and amantadine). I was the Principal Investigator for UF site of the NIH-sponsored Adaptive COVID-19 Treatment Trials (ACTT), which identified remdesivir and baricitinib as important agents for the treatment of COVID patients. Most recently, I am the Principal Investigator for the UF site of the STOMP monkeypox clinical trial, and for the Accelerating COVID-19 Therapeutic Interventions and Vaccines clinical trials (ACTIV4a and ACTIV4d).

Open Researcher and Contributor ID (ORCID)

0000-0002-5032-6485

Publications

Academic Articles

Grants

Education

  1. Fellowship – Infectious Disease

    New York University

  2. Residency – Internal Medicine

    New York University

  3. Internship – Internal Medicine

    New York University

  4. Medical Degree

    New York University

  5. Doctor of Philosophy

    New York University

  6. Bachelor of Arts – Biology

    City University of New York

Contact Details

Phones:
Business:
(352) 273-8606
Emails:
Executive Assistant:
Kanah R Kittrell
View Profile
Addresses:
Business Mailing:
PO Box 100289
GAINESVILLE FL 32610
Business Street:
1600 SW Archer Road, D2-39
GAINESVILLE FL 32611